Summary:
NeuroGeneration develops stem cell therapy products that will have a major impact on the treatment of neurological diseases, including Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
Visit NeuroGeneration.

Description (Web site quote):
Founded in 1996 by Dr. Michel Levesque, our laboratories work with the isolation and characterization of human adult-derived neural stem cells that, when placed in experimental laboratory conditions stimulating certain genes, are "awakened" and begin to divide and replicate events of normal development.

NeuroGeneration is a clinical stage biotechnology company with neural stem cell products targeting neurological disorders caused by cell loss or injury. Our mission is to lead the field of neural stem cell therapy for neurological disorders and become the top provider of autologous neural stem cell therapy products.

Cell therapy is the most fascinating revolution in medicine currently underway. Cell therapy results from the understanding of complex molecular biology events triggering cellular division and development. With that knowledge, NeuroGeneration's scientists have reproduced divisional cell processes of adult human neural stem cells and regulated their differentiation to generate, in vitro,several millions of functional neurons. NeuroGeneration's products can be individualized to the uniqueness of each patient's disease and immunological profile, avoiding risks of viral transmission and rejection. NeuroGeneration was founded to develop effective new therapies for patients faced with irreversible illnesses.
Visit NeuroGeneration.